← Back to All US Stocks

EHSI Stock Analysis 2026 - Elite Health Systems Inc. AI Rating

EHSI OTC Services-Specialty Outpatient Facilities, NEC DE CIK: 0001089815
Recently Updated • Analysis: Mar 24, 2026 • SEC Data: 2025-09-30
STRONG SELL
92% Conf
Pending
Analysis scheduled

📊 EHSI Key Takeaways

Revenue: $0.0
Net Margin: N/A
Free Cash Flow: $-1.4M
Current Ratio: 15.83x
Debt/Equity: 0.82x
EPS: $-0.03
AI Rating: STRONG SELL with 92% confidence

Is EHSI a Good Investment? Thesis Analysis

Claude

Elite Health Systems is a distressed company with zero revenue generation, persistent operating losses of $2M, and deteriorating cash position despite holding $4M in cash reserves. The company is burning cash at an unsustainable rate with negative free cash flow of $1.4M and negative ROE/ROA metrics, indicating fundamental operational failure in a specialty outpatient healthcare services business.

Why Buy EHSI? Key Strengths

Claude
  • + Strong liquidity position with $4M cash and 15.83x current ratio
  • + Low absolute liabilities at $291K relative to assets
  • + Positive stockholders equity of $5M provides technical solvency cushion

EHSI Investment Risks to Consider

Claude
  • ! Complete revenue collapse to $0 indicates loss of all business operations or reporting failure
  • ! Sustained negative operating cash flow of $1.4M depleting cash reserves rapidly at current burn rate
  • ! Negative returns on equity (-40.4%) and assets (-38.1%) demonstrate fundamental business failure and capital destruction
  • ! Long-term debt of $4.1M creates refinancing pressure as cash reserves deplete
  • ! Negative interest coverage of -2036x indicates inability to service debt from operations

Key Metrics to Watch

Claude
  • * Revenue generation and return to positive sales figures
  • * Monthly cash burn rate and timeline to cash depletion
  • * Operating cash flow stabilization and path to breakeven
  • * Debt restructuring or refinancing activities
  • * Management changes or strategic pivots in SEC filings

EHSI Financial Metrics

Revenue
$0.0
Net Income
$-2.0M
EPS (Diluted)
$-0.03
Free Cash Flow
$-1.4M
Total Assets
$5.3M
Cash Position
$4.0M

💡 AI Analyst Insight

Strong liquidity with a 15.83x current ratio provides a solid financial cushion.

EHSI Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE -40.4%
ROA -38.1%
FCF Margin N/A

EHSI vs Default Sector

How Elite Health Systems Inc. compares to Default sector averages

Net Margin
EHSI 0.0%
vs
Sector Avg 12.0%
EHSI Sector
ROE
EHSI -40.4%
vs
Sector Avg 15.0%
EHSI Sector
Current Ratio
EHSI 15.8x
vs
Sector Avg 1.8x
EHSI Sector
Debt/Equity
EHSI 0.8x
vs
Sector Avg 0.7x
EHSI Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is EHSI Overvalued or Undervalued?

Based on fundamental analysis, Elite Health Systems Inc. has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
-40.4%
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.82x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

EHSI Balance Sheet & Liquidity

Current Ratio
15.83x
Quick Ratio
15.83x
Debt/Equity
0.82x
Debt/Assets
5.5%
Interest Coverage
-2,036.00x
Long-term Debt
$4.1M

EHSI 5-Year Financial Trend & Growth Analysis

EHSI 5-year financial data: Year 2020: Revenue $3.2M, Net Income $142.0K, EPS N/A. Year 2021: Revenue $3.2M, Net Income $533.0K, EPS $0.07. Year 2022: Revenue $1.1M, Net Income -$881.0K, EPS $-0.11. Year 2023: Revenue $0, Net Income -$1.3M, EPS $-0.17. Year 2024: Revenue $0, Net Income N/A, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Elite Health Systems Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.17 indicates the company is currently unprofitable.

EHSI Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

EHSI Quarterly Performance

Quarterly financial performance data for Elite Health Systems Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 N/A -$290.0K N/A
Q2 2025 N/A -$312.0K N/A
Q1 2025 N/A -$312.0K N/A
Q3 2024 N/A -$127.0K N/A
Q2 2024 N/A -$434.0K N/A
Q1 2024 N/A -$108.0K $-0.01
Q3 2023 N/A -$127.0K $-0.02
Q2 2023 N/A -$434.0K $-0.05

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

EHSI Capital Allocation

Operating Cash Flow
-$1.4M
Cash generated from operations
Dividends
None
No dividend program

EHSI SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for Elite Health Systems Inc. (CIK: 0001089815)

📋 Recent SEC Filings

Date Form Document Action
Jan 8, 2026 4 xslF345X05/rdgdoc.xml View →
Dec 3, 2025 4 xslF345X05/rdgdoc.xml View →
Nov 13, 2025 10-Q ehsi20250930_10q.htm View →
Nov 5, 2025 8-K ehsi20251105_8k.htm View →
Sep 29, 2025 DEF 14A ehsi20250925_def14a.htm View →

Frequently Asked Questions about EHSI

What is the AI rating for EHSI?

Elite Health Systems Inc. (EHSI) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are EHSI's key strengths?

Claude: Strong liquidity position with $4M cash and 15.83x current ratio. Low absolute liabilities at $291K relative to assets.

What are the risks of investing in EHSI?

Claude: Complete revenue collapse to $0 indicates loss of all business operations or reporting failure. Sustained negative operating cash flow of $1.4M depleting cash reserves rapidly at current burn rate.

What is EHSI's revenue and growth?

Elite Health Systems Inc. reported revenue of $0.0.

Does EHSI pay dividends?

Elite Health Systems Inc. does not currently pay dividends.

Where can I find EHSI SEC filings?

Official SEC filings for Elite Health Systems Inc. (CIK: 0001089815) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is EHSI's EPS?

Elite Health Systems Inc. has a diluted EPS of $-0.03.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is EHSI a good stock to buy right now?

Based on our AI fundamental analysis in March 2026, Elite Health Systems Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is EHSI stock overvalued or undervalued?

Valuation metrics for EHSI: ROE of -40.4% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy EHSI stock in 2026?

Our dual AI analysis gives Elite Health Systems Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is EHSI's free cash flow?

Elite Health Systems Inc.'s operating cash flow is $-1.4M, with capital expenditures of N/A.

How does EHSI compare to other Default stocks?

Vs Default sector averages: Net margin N/A (avg: 12%), ROE -40.4% (avg: 15%), current ratio 15.83 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 24, 2026 | Data as of: 2025-09-30 | Powered by Claude AI